Gene · 9368
Papers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis. | Theranostics | 2023 | 37064875 | PubTator, text mining | PubMed |
| PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types. | Theranostics | 2023 | 37064866 | PubTator, text mining | PubMed |
| LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway. | J Cancer | 2023 | 37057285 | PubTator, text mining | PubMed |
| Construct ceRNA Network and Risk Model of Breast Cancer Using Machine Learning Methods under the Mechanism of Cuproptosis. | Diagnostics (Basel) | 2023 | 36980514 | PubTator, text mining | PubMed |
| Ezrin expression in female reproductive tissues: A review of regulation and pathophysiological implications. | Front Cell Dev Biol | 2023 | 36968198 | PubTator, text mining | PubMed |
| Identification of circRNA-miRNA-mRNA regulatory network and its role in cardiac hypertrophy. | PLoS One | 2023 | 36952519 | PubTator, text mining | PubMed |
| A Primer in Precision Nephrology: Optimizing Outcomes in Kidney Health and Disease through Data-Driven Medicine. | Kidney360 | 2023 | 36951457 | PubTator, text mining | PubMed |
| A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor-positive disease. | Cancer Med | 2023 | 36938826 | PubTator, text mining | PubMed |
| Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium. | Signal Transduct Target Ther | 2023 | 36918546 | PubTator, text mining | PubMed |
| Benefits of co-translational complex assembly for cellular fitness. | Bioessays | 2023 | 36916749 | PubTator, text mining | PubMed |
| HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer. | PLoS Pathog | 2023 | 36867660 | PubTator, text mining | PubMed |
| The Usher syndrome 1C protein harmonin regulates canonical Wnt signaling. | Front Cell Dev Biol | 2023 | 36846582 | PubTator, text mining | PubMed |
| Prognostic 7-SLC-Gene Signature Identified via Weighted Gene Co-Expression Network Analysis for Patients with Hepatocellular Carcinoma. | J Oncol | 2023 | 36844876 | PubTator, text mining | PubMed |
| Complexification of In Vitro Models of Intestinal Barriers, A True Challenge for a More Accurate Alternative Approach. | Int J Mol Sci | 2023 | 36835003 | PubTator, text mining | PubMed |
| Quantitative Proteomic Characterization of Foreign Body Response towards Silicone Breast Implants Identifies Chronological Disease-Relevant Biomarker Dynamics. | Biomolecules | 2023 | 36830674 | PubTator, text mining | PubMed |
| Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report. | Open Med (Wars) | 2023 | 36820062 | PubTator, text mining | PubMed |
| Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. | Mol Cancer | 2023 | 36810071 | PubTator, text mining | PubMed |
| Hydration and Nephrolithiasis in Pediatric Populations: Specificities and Current Recommendations. | Nutrients | 2023 | 36771434 | PubTator, text mining | PubMed |
| Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure. | Int J Mol Sci | 2023 | 36768972 | PubTator, text mining | PubMed |
| Ion Channels in Gliomas-From Molecular Basis to Treatment. | Int J Mol Sci | 2023 | 36768856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9368/papers?page=7